Home›Trial›NCT06456580
🔬NCT06456580Phase 3RECRUITING

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

Study Summary

The purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of generalized myasthenia gravis.

Conditions
Generalized Myasthenia Gravis
Interventions / Drugs
TelitaciceptPlacebo
View on ClinicalTrials.gov ↗
Sponsor
VOR
Vor Biopharma
Cell Therapy
C64/100
Study Details
Enrollment180 participants
Primary Completion—
Lead SponsorVor Biopharma
Data Retrieved2026-04-11 04:31:09.587460+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.